Fundraising Fox

Coave Therapeutics

Paris, FR · 8 known investors

Coave Therapeutics is a biotech company developing gene therapies based on AAV vector engineering and genetic construct design, targeting neurodegenerative and ocular diseases. It is developing OneAAV, a universal capsid intended for next-generation gene therapy vectors.

BiotechHealthtech

Investors · 8

Fund+Leuven · $5.5M – $16.5M
Kurma PartnersParis · $162K – $10.8M
Seroba Life SciencesDublin · $540K – $7.6M
V-Bio VenturesGhent · $270K – $2.2M
BpifrancereportedParis, Ile-De-France · $270K
InvusreportedNew York
Novo HoldingsreportedCopenhagen · $1.1M – $54M
UI InvestissementreportedParis

Funding

SEC filings, press & company announcements

Source: company announcements and press reports — follow each round's link for the claim.

In the news

Coave Therapeutics Launches CNS-Targeted Gene Therapy Capsid Developed with Proprietary Platform | BioPharm Internationalbiopharminternational.com · May 2026Coave raises $33m funding to advance ALIGATER platformpharmaceutical-technology.com · Jan 2025Coave Therapeutics Secures €32 Million ($33 Million) in Series A Financing to Advance its Next-Generation Genetic Medicinesglobenewswire.com · Jan 2025Coave Therapeutics Closes €33M in Series B Financing - FinSMEsfinsmes.com · Jul 2021Coave Therapeutics Closes €33 million ($39 million) Series B Financing to Develop its Gene Therapy Pipeline and Next-Generation Vectors based on its AAV-Ligand Conjugate Platformprnewswire.com · Jul 2021

Frequently asked questions

What does Coave Therapeutics do?
Coave Therapeutics is a biotech company developing gene therapies based on AAV vector engineering and genetic construct design, targeting neurodegenerative and ocular diseases. It is developing OneAAV, a universal capsid intended for next-generation gene therapy vectors.
Who are Coave Therapeutics's investors?
Coave Therapeutics's investors include Fund+, Kurma Partners, Seroba Life Sciences, V-Bio Ventures, Bpifrance, Invus, Novo Holdings, UI Investissement.
Where is Coave Therapeutics headquartered?
Coave Therapeutics is headquartered in Paris, FR.